Financial

News

Novo Nordisk weakens again on interim results readout

Novo Nordisk's already depressed share price has fallen again this morning, despite reporting an 18% increase in sales in the first half of this year.

News

GSK suffers a setback with its TIM-3 programme

GSK has become the latest drugmaker to run into difficulties in developing a drug targeting the immune checkpoint receptor TIM-3.

News

Novo Nordisk slumps as it cuts sales forecast, names new CEO

Novo Nordisk has a new CEO, facing an uphill battle to restore the fortunes of its US business as diabetes and obesity drugs come under pressure.

News

MSD trims outlook as it aims to shave $3bn off costs

MSD is embarking on a $3bn cost-reduction drive to prepare for the loss of patent protection for cancer blockbuster Keytruda.

News

Bayer extends CEO contract amid 'signs of success'

Bayer's chief executive Bill Anderson looks set to keep his role until nearly the decade, as his turnaround plan starts to deliver results.

News

AstraZeneca CEO Soriot said to be looking at US listing

AstraZeneca chief executive Pascal Soriot is reportedly considering moving the company's stock exchange listing from the UK to the US.

Novo Nordisk weakens again on interim results readout

GSK suffers a setback with its TIM-3 programme

Novo Nordisk slumps as it cuts sales forecast, names new CEO

MSD trims outlook as it aims to shave $3bn off costs

Bayer extends CEO contract amid 'signs of success'

AstraZeneca CEO Soriot said to be looking at US listing

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

Financial

Editor's Picks